Eric Lefebvre - Mar 21, 2022 Form 4 Insider Report for CymaBay Therapeutics, Inc. (CBAY)

Role
Director
Signature
/s/ Paul Quinlan, as attorney-in-fact for Eric Lefebvre
Stock symbol
CBAY
Transactions as of
Mar 21, 2022
Transactions value $
$0
Form type
4
Date filed
3/21/2022, 05:40 PM
Previous filing
Feb 2, 2022
Next filing
Jul 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBAY Stock Option (right to buy) Award $0 +115K $0.00 115K Mar 21, 2022 Common Stock 115K $3.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/36 of the underlying shares monthly from March 21, 2022.